bioRxivImmunologyPreprint
Persistent Activation of Chronic Inflammatory Pathways in Long Covid
Malika AïdiD, Katherine McMahaniD, Nicole P. HachmanniD, Jessica J MilleriD, Erica N. Borducchi, David L. HopeiD, Marjorie RoweiD, Eleanor Schonberg, Siline Thai, Ai-ris Yonekura CollieriD, Janet M. MullingtoniD, Dan H. BarouchiD
Abstract
Long Covid, or Post-Acute Sequelae of COVID-19 (PASC), involves a spectrum of chronic symptoms following resolution of acute SARS-CoV-2 infection. Current hypotheses for the pathogenesis of Long Covid include persistent SARS-CoV-2, activation of other viruses, tissue damage, autoimmunity, endocrine insufficiency, immune dysfunction, and complement activation. We evaluated 142 participants, including uninfected controls (N=35), acutely infected individuals (N=54), convalescent controls (N=25), and Long Covid patients (N=28), by comprehensive immunologic, virologic, transcriptomic, and proteomic analyses. Long Covid was characterized by persistent inflammatory pathways compared with convalescent controls and uninfected controls, including upregulation of IL-6 and JAK-STAT pathways as well as activation of coagulation, complement, metabolism, and T cell exhaustion pathways. Moreover, robust activation of these pathways during acute COVID-19 infection correlated with the subsequent development of Long Covid. In an independent validation cohort (N=47), Long Covid patients had higher levels of plasma IL-6R compared with convalescent controls and uninfected controls. These data demonstrate that Long Covid is characterized by persistent activation of chronic inflammatory pathways, suggesting novel therapeutic targets and biomarkers of disease.
- organism: human
- assay: proteomics
- assay: bulk RNA-seq
- assay: metabolomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Persistent serum protein signatures define an inflammatory subset of long COVID
A. Talla, S. V. Vasaikar, … T. R. Torgerson·bioRxiv·May 9, 2022
- Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
K. Yin, M. J. Peluso, … N. R. Roan·bioRxiv·Feb 9, 2023
- Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence
A. Talla, S. V. Vasaikar, … T. F. Bumol·bioRxiv·May 26, 2021
- Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins
Marcin Kwissa, Manikannan Mathayan, … Jalees Rehman·bioRxiv·Aug 18, 2025
- Persistently activated virus-specific CD8 T cells indicate antigen-driven immune aberrations in long COVID
Mark M. Painter, David B. Reeg, … E. John Wherry·bioRxiv·Oct 22, 2026
- Increased migratory/activated CD8+ T cell and low avidity SARS-CoV-2 reactive cellular response in post-acute COVID-19 syndrome
K. Paniskaki, M. Konik, … N. Babel·bioRxiv·Dec 3, 2022